The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sixteen years follow-up results of a randomized phase II trial of neoadjuvant FAC compared with CMF in stage III breast cancer.
Ariel Osvaldo Zwenger
No relevant relationships to disclose
Julieta Leone
No relevant relationships to disclose
Carlos Teodoro Vallejo
No relevant relationships to disclose
Juan Eduardo Perez
No relevant relationships to disclose
Alberto Omar Romero
No relevant relationships to disclose
Mario Raul Machiavelli
No relevant relationships to disclose
Luis Romero Acuna
No relevant relationships to disclose
Maria Ester Dominguez
No relevant relationships to disclose
Mario Langui
No relevant relationships to disclose
Hebe Margot Fasce
No relevant relationships to disclose
Bernardo Amadeo Leone
No relevant relationships to disclose
Eduardo Ortiz
No relevant relationships to disclose
Jose Pablo Leone
No relevant relationships to disclose
Julian Iturbe
No relevant relationships to disclose